Xeris Biopharma Holdings annual total assets
2020
2021
2022
2023
2024
2025
Xeris Biopharma Holdings Total Assets Growth & History (XERS)
Xeris Biopharma Holdings's total assets was $383.5M for fiscal 2025.
View full Xeris Biopharma Holdings company overviewXeris Biopharma Holdings annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $383.5M | $60.5M | +18.72% |
| 2024 | 2024-12-31 | $323.1M | $458,000 | +0.14% |
| 2023 | 2023-12-31 | $322.6M | −$21.9M | −6.36% |
| 2022 | 2022-12-31 | $344.5M | $40.2M | +13.20% |
| 2021 | 2021-12-31 | $304.4M | $145.2M | +91.24% |
| 2020 | 2020-12-31 | $159.2M | — | — |
Xeris Biopharma Holdings quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $411.9M | $77.2M | +23.07% |
| Q1 2026 | 2026-03-31 | $392.0M | $76.6M | +24.27% |
| Q4 2025 | 2025-12-31 | $383.5M | $60.5M | +18.72% |
| Q3 2025 | 2025-09-30 | $370.2M | $49.1M | +15.29% |
| Q2 2025 | 2025-06-30 | $334.7M | $3.0M | +0.89% |
| Q1 2025 | 2025-03-31 | $315.5M | — | — |
| Q4 2024 | 2024-12-31 | $323.1M | $458,000 | +0.14% |
| Q3 2024 | 2024-09-30 | $321.1M | −$6.7M | −2.04% |
| Q2 2024 | 2024-06-30 | $331.7M | — | — |
| Q4 2023 | 2023-12-31 | $322.6M | −$21.9M | −6.36% |
| Q3 2023 | 2023-09-30 | $327.8M | $24.8M | +8.17% |
| Q4 2022 | 2022-12-31 | $344.5M | $40.2M | +13.20% |
| Q3 2022 | 2022-09-30 | $303.0M | $171.8M | +130.85% |
| Q2 2022 | 2022-06-30 | $318.6M | — | — |
| Q1 2022 | 2022-03-31 | $337.6M | — | — |
| Q4 2021 | 2021-12-31 | $304.4M | $145.2M | +91.24% |
| Q3 2021 | 2021-09-30 | $131.3M | — | — |
| Q4 2020 | 2020-12-31 | $159.2M | — | — |
Xeris Biopharma Holdings total assets trends
Over the last five fiscal years, Xeris Biopharma Holdings's total assets increased from $159.2M to $383.5M, a change of $224.4M. The latest reported quarter, Q2 2026, shows $411.9M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xeris Biopharma Holdings source filings ↗